Status:
COMPLETED
Solar Lentigines Treatment With the Triple Combination Cream
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Collaborating Sponsors:
Galderma R&D
Conditions:
Lentigo
Eligibility:
All Genders
30-80 years
Phase:
PHASE2
Brief Summary
Background * Lentigines are usually the first sign of photoaging and may produce a significant impact on patients' quality of life. * There is no a treatment of choice for this condition. * Solar len...
Eligibility Criteria
Inclusion
- Subjects of both sexes of 30 - 80 years of age.
- Phototype II-V.
- Postmenopausal women of childbearing age or users of any contraception method with negative pregnancy test (beta subunit chorionic gonadotropin in the blood) at baseline and that maintain the contraceptive treatment during the investigation.
- Subjects with more than 10 solar lentigines on the back of each hand wich were no treated in the last 6 months
Exclusion
- Patients under 30 or over 80 years of age.
- Skin types I and VI.
- Less than 10 solar lentigines on the back of each hand.
- Patients who have received or are receiving any other treatment for lentigines of the back of hands.
- Women of childbearing age without contraceptive therapy.
- Pregnancy or lactation.
- History of hypersensitivity to any component of the drugs.
- Simultaneous use of other topical skin lightening.
- Patient refusal to participate in the study.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00975312
Start Date
August 1 2008
End Date
February 1 2009
Last Update
September 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pontificia Universidad Católica de Chile
Santiago, Santiago Metropolitan, Chile, 6904413